A study on low-dose aspirin for venous thromboembolism (VTE) published in the Journal of Arthroplasty is featured in Orthopedics Today with a Perspective by Jay R. Lieberman, MD, who is an editorial board member and Past President of AAHKS. According to Dr. Lieberman, “The selection of a prophylaxis regimen after TKA is a balance between efficacy and safety. Aspirin provides effective prophylaxis, but it remains unknown whether a low dose is as effective as, but also safer than a high dose.” Full story.
Perspective Given on Study of Low-Dose Aspirin for VTE
This Week’s Featured Industry Symposium: Surgical Techniques and Instrumentation AJRR Steering Committee Meets